About Theradaptive
Theradaptive is a company based in Boston (United States) founded in 2004.. Theradaptive has raised $32.2 million across 6 funding rounds from investors including TEDCO, ORTHOREBIRTH and Maryland Stem Cell Research Fund. The company has 21 employees as of December 31, 2022. Theradaptive offers products and services including Protein Engineering Platform, OASIS Trial, and Preclinical Studies. Theradaptive operates in a competitive market with competitors including MiMedx Group, Ossio, EpiBone, Biocomposites and CartiHeal, among others.
- Headquarter Boston, United States
- Employees 21 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Theradaptive, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$32.2 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
TEDCO
& 4 more
-
Employee Count
21
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Theradaptive
Theradaptive offers a comprehensive portfolio of products and services, including Protein Engineering Platform, OASIS Trial, and Preclinical Studies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops modified proteins for targeted therapeutic delivery in clinical applications.
Conducts trials for protein-based therapeutics in medical treatments.
Performs studies on protein variants for various indications.
Unlock access to complete
Funding Insights of Theradaptive
Theradaptive has successfully raised a total of $32.2M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(01 Jun 2018)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Grant - Theradaptive | Valuation |
investors |
|
| Jul, 2023 | Amount | Grant - Theradaptive | Valuation |
investors |
|
| Jun, 2023 | Amount | Series A - Theradaptive | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Theradaptive
Theradaptive has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include TEDCO, ORTHOREBIRTH and Maryland Stem Cell Research Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stem cell research startups in healthcare are funded and accelerated.
|
Founded Year | Domain | Location | |
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Founded Year | Domain | Location | |
|
Cottony type synthetic bone void filling material
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Theradaptive
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Theradaptive
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Theradaptive Comparisons
Competitors of Theradaptive
Theradaptive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Ossio, EpiBone, Biocomposites and CartiHeal, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
|
| domain | founded_year | HQ Location |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| domain | founded_year | HQ Location |
Implants for bone and cartilage regeneration are developed and provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Theradaptive
Frequently Asked Questions about Theradaptive
When was Theradaptive founded?
Theradaptive was founded in 2004 and raised its 1st funding round 14 years after it was founded.
Where is Theradaptive located?
Theradaptive is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Theradaptive a funded company?
Theradaptive is a funded company, having raised a total of $32.2M across 6 funding rounds to date. The company's 1st funding round was a Series A of $26M, raised on Jun 01, 2018.
How many employees does Theradaptive have?
As of Dec 31, 2022, the latest employee count at Theradaptive is 21.
What does Theradaptive do?
Theradaptive was founded in 2004 and is headquartered in Boston, United States. A therapeutic delivery platform is developed for various orthopedic clinical indications within the biotechnology sector. Solutions are offered for conditions such as spinal fusion, trauma repair, dental repair, and complex cartilage repair. Therapeutics are delivered to support targeted native tissue repair across multiple applications.
Who are the top competitors of Theradaptive?
Theradaptive's top competitors include EpiBone, MiMedx Group and Ossio.
What products or services does Theradaptive offer?
Theradaptive offers Protein Engineering Platform, OASIS Trial, and Preclinical Studies.
Who are Theradaptive's investors?
Theradaptive has 5 investors. Key investors include TEDCO, ORTHOREBIRTH, Maryland Stem Cell Research Fund, U.S. Department of Defense, and Military Health.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.